Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1991 2
1995 1
1998 2
2001 3
2002 1
2003 1
2004 1
2005 2
2006 1
2010 1
2012 1
2013 1
2014 3
2015 1
2016 3
2017 2
2018 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.
Paller CJ, Wang L, Fu W, Kumar R, Durham JN, Azad NS, Laheru DA, Browner I, Kachhap SK, Boyapati K, Odeny T, Armstrong DK, Meyer CF, Gaillard S, Brahmer JR, Page I, Wang H, Diaz LA Jr. Paller CJ, et al. Cancer Res Commun. 2023 Feb 28;3(2):338-346. doi: 10.1158/2767-9764.CRC-23-0002. eCollection 2023 Feb. Cancer Res Commun. 2023. PMID: 36860652 Free PMC article. Clinical Trial.
PURPOSE: Mistletoe extract (ME) is widely used for patients with cancer to support therapy and to improve quality of life (QoL). ...Future phase II trials are warranted. SIGNIFICANCE: Although ME is widely used for cancers, its efficacy and safety are uncerta …
PURPOSE: Mistletoe extract (ME) is widely used for patients with cancer to support therapy and to improve quality of life (QoL …
Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.
Zuzak TJ, Wasmuth A, Bernitzki S, Schwermer M, Längler A. Zuzak TJ, et al. Complement Ther Med. 2018 Oct;40:198-202. doi: 10.1016/j.ctim.2018.01.002. Epub 2018 Jan 11. Complement Ther Med. 2018. PMID: 30219449
Recent studies have shown direct positive effects on tumor reduction through Viscum album (mistletoe) extracts in adults, mainly as a result of higher dosage treatment and intravenous or intratumoral application. PATIENTS AND METHOD: A retrospective analysis of data …
Recent studies have shown direct positive effects on tumor reduction through Viscum album (mistletoe) extracts in adults, mainly as a …
Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors.
Kienle GS, Mussler M, Fuchs D, Kiene H. Kienle GS, et al. Evid Based Complement Alternat Med. 2016;2016:4628287. doi: 10.1155/2016/4628287. Epub 2016 Apr 24. Evid Based Complement Alternat Med. 2016. PMID: 27239209 Free PMC article.
Background. Mistletoe therapy (MT) is widely used in patient-centered integrative cancer care. ...The underlying goal is to help patients to live with and overcome disease. Mistletoe infusions are a means of accomplishing this goal. They are applied to stabil …
Background. Mistletoe therapy (MT) is widely used in patient-centered integrative cancer care. ...The underlying goal is to he …
Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study.
Steele ML, Axtner J, Happe A, Kröz M, Matthes H, Schad F. Steele ML, et al. Evid Based Complement Alternat Med. 2014;2014:236310. doi: 10.1155/2014/236310. Epub 2014 May 15. Evid Based Complement Alternat Med. 2014. PMID: 24955100 Free PMC article.
Treatment with intravenous mistletoe applications is described. The frequency of adverse drug reactions (ADRs) to intravenous mistletoe applications was calculated and compared to ADR data from a study on subcutaneous applications. Results. Of 475 c …
Treatment with intravenous mistletoe applications is described. The frequency of adverse drug reactions (ADRs) to intraveno …
Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects.
Lederer AK, Rieger S, Schink M, Huber R. Lederer AK, et al. Pharmaceuticals (Basel). 2024 Feb 22;17(3):278. doi: 10.3390/ph17030278. Pharmaceuticals (Basel). 2024. PMID: 38543063 Free PMC article.
Mistletoe lectins (ML) have cytotoxic and immunomodulating properties, and subcutaneously applied mistletoe products (MP) containing ML have approval for supportive cancer treatment. MP are also given off-label intravenously, but data about pharmacokin …
Mistletoe lectins (ML) have cytotoxic and immunomodulating properties, and subcutaneously applied mistletoe products (MP) cont …
Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study.
Schläppi M, Ewald C, Kuehn JJ, Weinert T, Huber R. Schläppi M, et al. Integr Cancer Ther. 2017 Dec;16(4):479-484. doi: 10.1177/1534735416658121. Epub 2016 Jul 7. Integr Cancer Ther. 2017. PMID: 27387685 Free PMC article.
PURPOSE: So-called spontaneous remissions in cancer often seem to occur after febrile events. Mistletoe preparations (MPs) are used off-label intravenously to induce fever within concepts of integrative oncology. We wanted to investigate the frequency of febr …
PURPOSE: So-called spontaneous remissions in cancer often seem to occur after febrile events. Mistletoe preparations (MPs) are …
Complete Remission of BCG-Refractory High-grade Bladder CIS with Pharmacologic Ascorbate and Mistletoe.
Davis D, Seely D, Morash C, Armstrong J, Meng M, Lowe P, Kogan M. Davis D, et al. Altern Ther Health Med. 2023 May;29(4):6-17. Altern Ther Health Med. 2023. PMID: 36933241 Free article.
PARTICIPANT: The patient in the case study was a 76-year-old, well-nourished, athletic, nonsmoking female with high-grade CIS of the bladder. Her cancer was considered to be a sentinel environmental cancer. INTERVENTION: Intravenous pharmacologic ascorbate (P …
PARTICIPANT: The patient in the case study was a 76-year-old, well-nourished, athletic, nonsmoking female with high-grade CIS of the bladder …
Anticancer activity of a lectin-rich mistletoe extract injected intratumorally into human pancreatic cancer xenografts.
Rostock M, Huber R, Greiner T, Fritz P, Scheer R, Schueler J, Fiebig HH. Rostock M, et al. Anticancer Res. 2005 May-Jun;25(3B):1969-75. Anticancer Res. 2005. PMID: 16158932 Free article.
-injected lectin-rich mistletoe extract at different dosages and i.t.-injected mistletoe lectin I in comparison to intravenous (i.v.) Gemcitabine and i.t. treatment with placebo in a human pancreatic cancer xenograft. RESULTS: In a preliminary dose-res …
-injected lectin-rich mistletoe extract at different dosages and i.t.-injected mistletoe lectin I in comparison to intraven …
Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A. Büssing A. Arzneimittelforschung. 2006 Jun;56(6A):508-15. doi: 10.1055/s-0031-1296818. Arzneimittelforschung. 2006. PMID: 16927532 Review.
One repeatedly finds that mistletoe (Viscum album L.) extracts show immune-modulating effects. ...However, patients with stronger local reaction showed a significant decrease of HLA-DR+ T cells as compared to patients In a GCP-conform, controlled bicentric phase II study t …
One repeatedly finds that mistletoe (Viscum album L.) extracts show immune-modulating effects. ...However, patients with stronger loc …
Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
Schad F, Atxner J, Buchwald D, Happe A, Popp S, Kröz M, Matthes H. Schad F, et al. Integr Cancer Ther. 2014 Jul;13(4):332-40. doi: 10.1177/1534735413513637. Epub 2013 Dec 19. Integr Cancer Ther. 2014. PMID: 24363283 Free article.
Here we report on 39 patients with advanced, inoperable pancreatic cancer, who received in total 223 intratumoral applications of mistletoe, endoscopic ultrasound guided or under transabdominal ultrasound control. ...Due to the multimodal therapeutic setting and the …
Here we report on 39 patients with advanced, inoperable pancreatic cancer, who received in total 223 intratumoral applications of …
30 results